--- title: FidoCure blog (3) description: Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates. (3) --- [![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/fidocure_logo.png?width=296&height=68&name=fidocure_logo.png "FidoCure")](https://www.fidocure.com/) - [Veterinarians](https://fidocure.com/for-veterinarians/) - [Portal Login](https://dvm.fidocure.com/) - [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet) - [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies) - [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars) - [Pet Parents](https://fidocure.com/pet-parents/) - [About Us](https://fidocure.com/about-us/) - [How it works](https://fidocure.com/how-it-works/) - [Find a Clinic](https://fidocure.com/find-a-clinic/) - [Contact Us](https://fidocure.com/contact-us/) # FidoCure Veterinary Team Blog ### Read the latest in veterinary oncology research and FidoCure scientific and clinical updates from our team of experts and advisors Select Category Case Studies Press Vet Webinars This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. ![](https://blog.fidocure.com/hubfs/Blog_HumanCancerDrugs.png) ### [Do Human Cancer Drugs Work on Dogs With Cancer?](https://blog.fidocure.com/fidocure-blog/do-human-cancer-drugs-work-on-dogs-with-cancer) At FidoCure, we're pioneering a revolutionary approach to treating canine cancer by bringing the power of precision medicine from human oncology to veterinary care. If your beloved dog has been diagnosed with cancer, you may have been told that the treatment options are limited. However, thanks to groundbreaking research and innovative technologies, there's new hope in the form of precision cancer drugs originally developed for humans. [Read More](https://blog.fidocure.com/fidocure-blog/do-human-cancer-drugs-work-on-dogs-with-cancer) ![](https://blog.fidocure.com/hubfs/Blog_HC.png) ### [Hepatocellular Carcinoma in Dogs: Understanding This Common Liver Cancer](https://blog.fidocure.com/fidocure-blog/hepatocellular-carcinoma-in-dogs-understanding-this-common-liver-cancer) Hepatocellular carcinoma (HCC) is the most common primary liver cancer in dogs. It can present as a single mass, multiple nodules, or diffuse spread throughout the liver, which increases the risk of metastasis. The main treatment options are surgical removal, metronomic chemotherapy, and/or Palladia. The prognosis is generally good for the single, massive form after surgery, but consulting a veterinary oncologist is recommended for all cases. [Read More](https://blog.fidocure.com/fidocure-blog/hepatocellular-carcinoma-in-dogs-understanding-this-common-liver-cancer) ![](https://blog.fidocure.com/hubfs/Blog_Pet%20Insurance.png) ### [How Pet Insurance Can Ease the Financial Burden of Cancer Treatment](https://blog.fidocure.com/fidocure-blog/how-pet-insurance-can-ease-the-financial-burden-of-cancer-treatment) When our beloved pets are diagnosed with cancer, it can be an emotionally and financially challenging time. As veterinary oncology advances, new and innovative cancer treatments are becoming available for our furry family members. However, these cutting-edge therapies can come with a significant price tag. [Read More](https://blog.fidocure.com/fidocure-blog/how-pet-insurance-can-ease-the-financial-burden-of-cancer-treatment) ![](https://blog.fidocure.com/hubfs/Blog_NasalAdenocarcinoma.png) ### [What to Know About Nasal Adenocarcinoma](https://blog.fidocure.com/fidocure-blog/what-to-know-about-nasal-adenocarcinoma) Nasal adenocarcinomas are relatively uncommon but represent nearly two-thirds of nasal tumors in dogs, which are locally invasive and have a higher risk of metastasis in later stages. Radiation therapy is the primary treatment to slow tumor growth, with patients living around one year on average. Newer approaches like metronomic chemotherapy and precision medicines targeting mutations show promise in delaying progression and metastasis.  [Read More](https://blog.fidocure.com/fidocure-blog/what-to-know-about-nasal-adenocarcinoma) ![](https://blog.fidocure.com/hubfs/Blog_PulmonaryAdenocarcinoma.png) ### [What to Know About Pulmonary Adenocarcinoma](https://blog.fidocure.com/fidocure-blog/what-to-know-about-pulmonary-adenocarcinoma) Pulmonary adenocarcinoma is a common and aggressive form of lung cancer in dogs, accounting for nearly 80% of canine lung neoplasia cases. The primary treatment is surgical tumor removal, sometimes combined with chemotherapy or radiation therapy for inoperable cases. Prognosis depends on tumor size and grade, ranging from over 16 months for small, low-grade tumors to only 3 months for high-grade, metastatic cancers despite treatment.  [Read More](https://blog.fidocure.com/fidocure-blog/what-to-know-about-pulmonary-adenocarcinoma) ![](https://blog.fidocure.com/hubfs/FC_DD_X.png) ### [FidoCure Celebrates National Dog Day](https://blog.fidocure.com/fidocure-blog/fidocure-celebrates-national-dog-day) Happy National Dog Day from all of us at FidoCure! Today, we celebrate the joy, companionship, and unconditional love that dogs bring into our lives. At FidoCure, our mission is to ensure that these beloved companions live longer, happier, and healthier lives, even when faced with the challenge of cancer. [Read More](https://blog.fidocure.com/fidocure-blog/fidocure-celebrates-national-dog-day) ![](https://blog.fidocure.com/hubfs/Blog_ChristinaForbes.png) ### [Forbes Interview: FidoCure CEO Thinks Drugs For Dogs Can Help Humans Fight Cancer](https://blog.fidocure.com/fidocure-blog/forbes-interview) [Read More](https://blog.fidocure.com/fidocure-blog/forbes-interview) ![](https://lh7-rt.googleusercontent.com/docsz/AD_4nXei6XP23_Pj84FLrHm1AtwbJm4CyB-_5ARN0owVzFZRNrO6Df023mMWeTT_B1R3n74SwV_u7B4xYRyqUtqmSnsoHLI1nrPq80XSmvY_tj3BsxRr5kWYijkNP7eq8Y_xezBF9mGFG2XkF_1NllOkPT9RPFA?key=SfYAIHXMZbRbOgm2t09y5w) ### [Understanding Mast Cell Tumors in Dogs](https://blog.fidocure.com/fidocure-blog/understanding-mast-cell-tumors-in-dogs) Mast cell tumors are the most common skin tumors in dogs, developing from abnormal growth of mast cells, which are normally involved in allergic and immune responses. Treatment depends on tumor grade, size, and spread, ranging from surgery to radiation therapy to systemic therapies like chemotherapy and/or targeted therapy. Low-grade tumors that are completely removed with surgery carry the best prognosis while high-grade or metastatic tumors often require therapy beyond surgery and carry a more guarded prognosis. As always, consulting a veterinarian or veterinary oncologist is recommended for staging and personalized treatment planning. [Read More](https://blog.fidocure.com/fidocure-blog/understanding-mast-cell-tumors-in-dogs) ![](https://blog.fidocure.com/hubfs/FC_KC_X.png) ### [FidoCure CEO Christina Lopes to Showcase World's First Portfolio of Canine Cancer Drugs at 2024 Animal Health Summit](https://blog.fidocure.com/fidocure-blog/fidocure-ceo-christina-lopes-to-showcase-worlds-only-portfolio-of-canine-cancer-drugs-at-2024-animal-health-summit) FidoCure CEO Christina Lopes will present at the 2024 Animal Health Summit in Kansas City on August 26-27. The summit will showcase emerging companies and foster connections between innovators, investors, and industry leaders in animal health, nutrition, and technology. Attendees can also expect 1:1 business partnering opportunities, interactive experiences, and presentations from some of the world's leading minds in the field. [Read More](https://blog.fidocure.com/fidocure-blog/fidocure-ceo-christina-lopes-to-showcase-worlds-only-portfolio-of-canine-cancer-drugs-at-2024-animal-health-summit) ![](https://blog.fidocure.com/hubfs/fc_round3-02.png) ### [FidoCure Secures Patent for AI-Driven Precision Medicine](https://blog.fidocure.com/fidocure-blog/fidocure-secures-patent-for-ai-driven-precision-medicine) **FidoCure to Transform the Precision Medicine Landscape with New Patent, Accelerating Drug Development for Dogs with Cancer** [Read More](https://blog.fidocure.com/fidocure-blog/fidocure-secures-patent-for-ai-driven-precision-medicine) [1](https://blog.fidocure.com/fidocure-blog) [2](https://blog.fidocure.com/fidocure-blog/page/2) [3](https://blog.fidocure.com/fidocure-blog/page/3) [4](https://blog.fidocure.com/fidocure-blog/page/4) [5](https://blog.fidocure.com/fidocure-blog/page/5) ![fc_portal_logo_bw](https://blog.fidocure.com/hubfs/fc_portal_logo_bw.svg) - [How it Works](https://fidocure.com/how-it-works/) - [FAQ](https://fidocure.com/faq/) - [Contact Us](https://fidocurestg.wpengine.com/contact-us/) - [For Vets](https://fidocure.com/for-veterinarians/) - [About Us](https://fidocure.com/about-us/) - [Terms of Service](https://fidocure.com/terms-of-service/) - [Blog](https://blog.fidocure.com/fidocure-blog) - [Careers](https://fidocure.com/careers/) - [Privacy Policy](https://fidocure.com/privacy-policy/) - - - - **FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.  © Copyright 2018-2026 One Health Company, All rights reserved